Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 02-May-24
Select bar for recommendation details.
Recommendations | 02-May-24 | |
---|---|---|
Buy | 3 | |
Outperform | 7 | |
Hold | 16 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in USD
The 22 analysts offering 12 month price targets for Pfizer Inc have a median target of 30.50, with a high estimate of 45.00 and a low estimate of 26.00. The median estimate represents a 9.67% increase from the last price of 27.81.
High | 61.8% | 45.00 |
Med | 9.7% | 30.50 |
Low | -6.5% | 26.00 |
Dividends in USD
Div growth (TTM) | 2.50% |
---|
More ▼
Earnings history & estimates in USD
The next earnings announcement is expected on Jul 30, 2024.
Average growth rate | +337.24% |
Average growth rate | +12.80% |
More ▼
Revenue history & estimates in USD
Average growth rate | -3.58% |
Average growth rate | +14.17% |
More ▼